financetom
Business
financetom
/
Business
/
CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions’ Expanded Credit Facility and Syndicate to Support Acquisition of Acterys
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions’ Expanded Credit Facility and Syndicate to Support Acquisition of Acterys
Apr 15, 2026 4:09 AM

TORONTO--(BUSINESS WIRE)--

CIBC Innovation Banking announced today its role as Lead Arranger and Administrative Agent in an expanded credit facility for Vena Solutions (Vena), a top-tier AI-powered Microsoft-native Financial Planning and Analysis (FP&A) platform that connects data, people and agents to help customers plan better and achieve more.

The increased financing and broadened syndicate are set to support Vena’s acquisition of Acterys, an industry-leading Microsoft Power BI-based operational planning and app development platform, and provide additional capital to fuel future growth for the newly combined organization. Existing investors include Vista Equity Partners, JMI Equity and Centana Growth Partners.

Having achieved Centaur status, surpassing US$100 million in annual recurring revenue, Vena continues to scale its platform and expand its presence within the Microsoft ecosystem. As part of this evolution, Vena continues to advance Vena AI, embedding intelligent AI agents directly within governed finance and operational workflows to help organizations act faster on better informed decisions using the tools their teams already know and trust.

“Our mission is to help organizations perform better and achieve more with greater clarity and confidence,” said Hunter Madeley, CEO of Vena. “The addition of Acterys brings complementary operational planning, analytics and app development capabilities that reinforce our commitment to serving finance and business leaders with connected, intelligent solutions that support orchestrated planning and on-time execution in an increasingly complex business environment.”

“We are thrilled to support Vena’s continued momentum in the enterprise performance management space,” said Adam Weiers, Managing Director, CIBC Innovation Banking. “This acquisition will enhance Vena’s leadership and market position, enabling the company to deliver even greater value and innovative solutions to clients globally.”

About CIBC Innovation Banking

CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across North America – a longer track record than most banks. CIBC Innovation Banking now has over $11 billion in funds managed including life sciences, health care, cleantech companies, investors, and entrepreneurs, and has assisted over 700 venture and private equity-backed businesses over the past six and a half years. The bank operates out of 14 global locations in San Francisco, Menlo Park, New York, Toronto, London, Austin, Boston, Chicago, Seattle, Vancouver, Montreal, Atlanta, Reston, and Durham. Connect with us today to start the conversation. Innovationbanking.cibc.com

About Vena

Vena is a Microsoft-native performance management platform that orchestrates financial and operational planning, analytics and execution across Microsoft Excel, Power BI, Azure and Fabric. With a governed, AI-ready data foundation and agentic AI embedded in planning workflows, Vena helps organizations make better decisions and execute with confidence. Thousands of organizations worldwide rely on Vena to perform better and achieve more.

About Acterys

Acterys provides enterprise-grade planning, analytics and application development solutions for Microsoft Power BI, Azure and Fabric. Its modular, scalable platform empowers organizations to build connected, data-driven applications at scale. Visit Acterys.com for more information.

Source: CIBC Innovation Banking

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Broadcom Expands Partnership With Meta for AI Compute Infrastructure
Broadcom Expands Partnership With Meta for AI Compute Infrastructure
Apr 15, 2026
06:28 AM EDT, 04/15/2026 (MT Newswires) -- Broadcom ( AVGO ) shares rose early Wednesday after the chipmaker expanded its partnership with Meta Platforms ( META ) to support the technology giant's artificial intelligence compute infrastructure. Broadcom ( AVGO ) will deploy technology for Meta's training and inference accelerator, or MTIA, silicon chips, under the multi-year deal, with plans to...
Canada To Suspend Fuel Excise Tax Through Summer, BMO Says
Canada To Suspend Fuel Excise Tax Through Summer, BMO Says
Apr 15, 2026
06:28 AM EDT, 04/15/2026 (MT Newswires) -- The Canadian government on Tuesday announced that it will suspend the excise tax on gasoline/diesel starting next Monday and running through Sept. 7 -- in other words, the entirety of the summer driving season, said Bank of Montreal (BMO). This will shave 10 cents per liter from retail gasoline prices, which have been...
CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions’ Expanded Credit Facility and Syndicate to Support Acquisition of Acterys
CIBC Innovation Banking Serves as Lead Arranger for Vena Solutions’ Expanded Credit Facility and Syndicate to Support Acquisition of Acterys
Apr 15, 2026
TORONTO--(BUSINESS WIRE)-- CIBC Innovation Banking announced today its role as Lead Arranger and Administrative Agent in an expanded credit facility for Vena Solutions (Vena), a top-tier AI-powered Microsoft-native Financial Planning and Analysis (FP&A) platform that connects data, people and agents to help customers plan better and achieve more. The increased financing and broadened syndicate are set to support Vena’s acquisition...
ARS Pharmaceuticals Says Health Canada Approves Neffy Nasal Spray
ARS Pharmaceuticals Says Health Canada Approves Neffy Nasal Spray
Apr 15, 2026
06:31 AM EDT, 04/15/2026 (MT Newswires) -- ARS Pharmaceuticals ( SPRY ) said Wednesday that Health Canada has approved its neffy 2mg nasal spray for the emergency treatment of anaphylaxis. The approval covers adults and children weighing at least 30 kilograms, providing patients with a needle-free option, the company said. The biopharmaceutical company said the nasal spray is expected to...
Copyright 2023-2026 - www.financetom.com All Rights Reserved